Event Date & TimeClick the calendar icon to add events
to your Personal Calendar
Digitally through the University of Manitoba
* You must be logged in to purchase event tickets.
October 2, 2021 session postponed to:
NEW DATE: APRIL 9, 2022 9:00 AM – 12:00 PM
Dental anxiety is an unfortunate reality for many Canadians. While there are a number of ways to address this situation for patients, one of the most effective is the use of oral sedatives. There are a number of categories of medications available for this purpose, including benzodiazepines, antihistamines, “natural” sleep aids (e.g. melatonin, camomile), and a host of others. One of the keys in the management of dentally anxious patients is for dentists is to learn to make the safest and most effective pharmacologic choices for them.
This course will focus on how to recognize patients that might benefit from minimal conscious sedation; that is, relaxation that allows patients to independently maintain their own airway while making their dental experience less frightening. Patients in this state can ask and answer questions during their appointment.
This course will include the following topics:
- Provincial sedation bylaws
- Appropriate patient selection and assessment
- Sedative medication pharmacology
- Oral sedation protocols
- Recognition and management of sedation emergencies
PLEASE NOTE: participants will have met the initial training requirements for administering a single oral agent, as outlined in the MDA’s “Bylaw for Pharmacological Behaviour Management”. Course participants must apply to be added to the MDA Sedation Roster prior to administration of oral agents.
- Review provincial sedation bylaws
- Conduct appropriate patient selection and assessment
- Understand sedative medication pharmacology
- Understand oral sedation protocols
- Recognize and manage sedation emergencies
Peter Nkansah, MSc, DDS, Dip. Anaes., FADSA, Specialist in Dental Anaes (ON), FPFA, FACD
Dr. Nkansah received both his DDS degree and Diploma in Dental Anaesthesia from the University of Toronto. He is a certified specialist in Dental Anaesthesia and maintains a private practice at Sleep For Dentistry in Toronto. In addition, he is an Assistant Professor at the University of Toronto’s Faculty of Dentistry as well as the Course Director for their intravenous conscious sedation continuing dental education course. Peter is the Course Director for both the conscious sedation continuing dental education course at Western University (Canada) and for Advanced Cardiac Life Support courses at Sunnybrook Health Sciences Centre. He is a member of the editorial board for the dental journal Oral Health. He is also a regular lecturer for dental groups nationally and internationally. On the sports front, one of his other areas of interest, Peter is the team dentist for the Toronto Raptors of the NBA, the Raptors 905 of the NBA’s G-League, the Toronto FC of the MLS, and the University of Toronto Varsity Blues
This event is available online only. You will be emailed connection information prior to the event.
Registrants can receive a refund provided they give written notice no later than fourteen (14) days prior to the event. An administration fee will be retained to cover staff costs of processing refunds and other costs associated with cancellations.
The University of Manitoba reserves the right to cancel or postpone any educational program due to an insufficient number of registrations. The decision to cancel will normally be made at least fourteen (14) days prior to the program date. Each registrant will be notified by email and provided with a full refund of all registration costs. The University of Manitoba is not liable for any loss, damages or other expenses that such cancellations may cause, including, but not limited to, non-refundable airline fares, hotel penalties or lost income.
This course provides up to 6 hours of Continuing Dental Education (CDE) Credits.
Rady Faculty of Health Sciences, University of Manitoba Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. The current term of approval extends from July 1, 2018 to June 30, 2022. Provider ID# 214210 Subject Code 340